1. Camandola S, Poli G, Mattson MP. The
lipid peroxidation product 4-hydroxy-2,3-nonenal increases AP-1-binding
activity through caspase activation in neurons. J Neurochem
2000;74(1):159-68.
2. Kingham PJ, Pocock JM. Microglial
apoptosis induced by chromogranin A is mediated by mitochondrial depolarisation
and the permeability transition but not by cytochrome c release.
J Neurochem 2000;74(4):1452-62.
3. Kobayashi T. The
roles of mitochondrial permeability transition in brain ischemia.
Hokkaido Igaku Zasshi 2000;75(4):243-52. (in Japanese)
4. Mather M, Rottenberg H. Aging
enhances the activation of the permeability transition pore in mitochondria.
Biochem Biophys Res Commun 2000;273(2):603-8.
5. Petersen A, Castilho RF, Hansson O, Wieloch T, Brundin P. Oxidative
stress, mitochondrial permeability transition and activation of caspases
in calcium ionophore A23187-induced death of cultured striatal neurons.
Brain Res. 2000;857(1-2):20-9.
6. Asai A, Qiu J, Narita Y, Chi S, Saito N, Shinoura N, et al. High
level calcineurin activity predisposes neuronal cells to apoptosis.
J Biol Chem 1999;274(48):34450-8.
7. Cassarino DS, Parks JK, Parker WD, Bennett JP. The
parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition
pore and releases cytochrome c in isolated mitochondria via an oxidative
mechanism. Biochim Biophys Acta 1999;1453(1):49-62.
8. Chalmers-Redman RM, Fraser AD, Carlile GW, Pong A, Tatton WG. Glucose
protection from MPP+-induced apoptosis depends on mitochondrial membrane
potential and ATP synthase. Biochem. Biophys. Res. Commun.
1999;257(2):440-7.
9. Sugrue MM, Wang Y, Rideout HJ, Chalmers-Redman RM, Tatton WG. Reduced
mitochondrial membrane potential and altered responsiveness of a mitochondrial
membrane megachannel in p53-induced senescence. Biochem Biophys
Res Commun 1999;261(1):123-30.
10. Cassarino DS, Parks JK, Parker WD, Jr., Bennett JP, Jr. The
parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition
pore and releases cytochrome c in isolated mitochondria via an oxidative
mechanism. Biochim Biophys Acta 1999;1453(1):49-62.
11. Chalmers-Redman RM, Fraser AD, Carlile GW, Pong A, Tatton WG. Glucose
protection from MPP+-induced apoptosis depends on mitochondrial membrane
potential and ATP synthase. Biochem Biophys Res Commun 1999;257(2):440-7.
12. Ferrand-Drake M, Friberg H, Wieloch T. Mitochondrial
permeability transition induced DNA-fragmentation in the rat hippocampus
following hypoglycemia. Neuroscience 1999;90(4):1325-38.
13. Kruman, II, Mattson MP. Pivotal
role of mitochondrial calcium uptake in neural cell apoptosis and necrosis.
J Neurochem 1999;72(2):529-40.
14. Ryu BR, Choi DW, Hartley DM, Costa E, Jou I, Gwag BJ. Attenuation
of cortical neuronal apoptosis by gangliosides. J Pharmacol Exp
Ther 1999;290(2):811-6.
15. Cassarino DS, Swerdlow RH, Parks JK, Parker WD, Jr., Bennett JP,
Jr. Cyclosporin
A increases resting mitochondrial membrane potential in SY5Y cells and
reverses the depressed mitochondrial membrane potential of Alzheimer's
disease cybrids. Biochem Biophys Res Commun 1998;248(1):168-73.
16. Dubinsky JM, Levi Y. Calcium-induced
activation of the mitochondrial permeability transition in hippocampal
neurons. J Neurosci Res 1998;53(6):728-41.
17. Fall CP, Bennett JP, Jr. MPP+
induced SH-SY5Y apoptosis is potentiated by cyclosporin A and inhibited
by aristolochic acid. Brain Res 1998;811(1-2):143-6.
18. Friberg H, Ferrand-Drake M, Bengtsson F, Halestrap AP, Wieloch T.
Cyclosporin
A, but not FK 506, protects mitochondria and neurons against hypoglycemic
damage and implicates the mitochondrial permeability transition in cell
death. J Neurosci 1998;18(14):5151-9.
19. Holtsberg FW, Steiner MR, Bruce-Keller AJ, et al. Lysophosphatidic
acid and apoptosis of nerve growth factor- differentiated PC12 cells.
J Neurosci Res 1998;53(6):685-96.
20. Holtsberg FW, Steiner MR, Keller JN, Mark RJ, Mattson MP, Steiner
SM. Lysophosphatidic
acid induces necrosis and apoptosis in hippocampal neurons. J
Neurochem 1998;70(1):66-76.
21. Huser J, Rechenmacher CE, Blatter LA. Imaging
the permeability pore transition in single mitochondria. Biophys
J 1998;74(4):2129-37.
22. Keller JN, Guo Q, Holtsberg FW, Bruce-Keller AJ, Mattson MP. Increased
sensitivity to mitochondrial toxin-induced apoptosis in neural cells
expressing mutant presenilin-1 is linked to perturbed calcium homeostasis
and enhanced oxyradical production. J Neurosci 1998;18(12):4439-50.
23. Keller JN, Kindy MS, Holtsberg FW, et al. Mitochondrial
manganese superoxide dismutase prevents neural apoptosis and reduces
ischemic brain injury: suppression of peroxynitrite production, lipid
peroxidation, and mitochondrial dysfunction. J Neurosci 1998;18(2):687-97.
24. Kruman, II, Nath A, Mattson MP. HIV-1
protein Tat induces apoptosis of hippocampal neurons by a mechanism
involving caspase activation, calcium overload, and oxidative stress.
Exp Neurol 1998;154(2):276-88.
25. Marzo I, Brenner C, Zamzami N, et al. The
permeability transition pore complex: a target for apoptosis regulation
by caspases and bcl-2-related proteins. J Exp Med 1998;187(8):1261-71.
26. Seaton TA, Cooper JM, Schapira AH. Cyclosporin
inhibition of apoptosis induced by mitochondrial complex I toxins.
Brain Res 1998;809(1):12-7.
27. Tatton WG, Chalmers-Redman RM. Mitochondria
in neurodegenerative apoptosis: an opportunity for therapy? Ann
Neurol 1998;44(3 Suppl 1):S134-41.
28. Wood AM, Bristow DR. N-methyl-D-aspartate
receptor desensitisation is neuroprotective by inhibiting glutamate-induced
apoptotic-like death. J Neurochem 1998;70(2):677-87.
29. Hortelano S, Dallaporta B, Zamzami N, et al. Nitric
oxide induces apoptosis via triggering mitochondrial permeability transition.
FEBS Lett 1997;410(2-3):373-7.
30. Ankarcrona M, Dypbukt JM, Orrenius S, Nicotera P. Calcineurin
and mitochondrial function in glutamate-induced neuronal cell death.
FEBS Lett 1996;394(3):321-4.
31. Siesjo BK, Siesjo P. Mechanisms
of secondary brain injury. Eur J Anaesthesiol 1996;13(3):247-68.
